• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Friday 11/16/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Predictive Technology Group

  • 2:04 PM

    Allowance Strengthens Commercialization Strategy of Company’s Proprietary Diagnostics and Therapeutics SALT LAKE CITY, UT, PRED,–(Marketwired – December 16, 2016) – Predictive Technology Group, Inc. (OTC PINK: PRED), a life sciences technology holding company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a fundamental patent application — US20160296671 -that covers the practice of administering “ANY” spine deformation therapeutics to a patient having a spine deformation altered risk associated biomarker. “We are pleased to see this latest

    Read more
  • 2:29 PM

    Company Introduces Its Latest Innovation in Regenerative Treatment Solutions SALT LAKE CITY, UT — PRED, (Marketwired) — Predictive Technology Group, Inc. (OTC PINK: PRED), announces that its wholly-owned subsidiary, Predictive Biotech, Inc. has finalized the development process of a new allograft stem cell product derived from umbilical cord blood(UCB). The use of UCB stem cells have gained popularity in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood and tissue

    Read more
  • 7:34 PM

    SALT LAKE CITY, UT–PRED, (Marketwired – February 16, 2016) – Predictive Technology Group, Inc. (OTC PINK: PRED) announces that it acquired the remaining minority position in Predictive Therapeutics, LLC. In March 2015, the Company acquired a majority stake, 84% control, in what is now the Company’s subsidiary, Predictive Therapeutics, LLC. A 16% minority stake has been acquired, and the Company has full 100% control of its subsidiary, Predictive Therapeutics, LLC. Brad Robinson, President, Predictive Technology Group, Inc. states, “Even though

    Read more
Public Wire Banner